Transform your drug development journey with Certara’s comprehensive solutions. From molecule to market, we seamlessly integrate science, technology, strategic and regulatory expertise to solve your unique challenges.
Navigate complex regulatory landscapes with tailored strategies and AI-driven tools.
Reduce development risk and accelerate decisions using predictive science and model-informed strategies.
Accelerate breakthroughs with biosimulation and modeling to refine candidates and improve go/no-go decisions.
Streamline IND submissions with predictive modeling and dosing optimization.
Achieve first-in-human success with advanced simulation and precision dosing.
Deliver robust regulatory-ready data while optimizing trial design and commercial planning.
Demonstrate value and optimize pricing for global patient access.
Unify insights to accelerate drug development and achieve development milestones. Partner with Certara to unlock your pipeline’s potential.
Certara’s software solutions offer transformative approaches across all drug development phases, aligning with recognized industry standards. By integrating advanced modeling, analytics, and automation, they break down silos, streamline workflows, and drive regulatory success.
PK, PD, and toxicokinetic analysis and modeling
Data standardization and validation
Integrate biological and pharmacological insights to optimize drug efficacy and safety predictions
Publish, review and transmit eCTD submissions
Tell your interactive, data-driven value story
Visualize nonclinical data for trends and outliers
Predict drug behavior in diverse populations using advanced PBPK modeling and simulation
Scientific informatics to access, analyze and visualize molecule and bioactivity
The AI platform designed for life sciences
GenAI, templates and structured content for regulatory writing
Enhance scientific discovery with chemical and biological intelligence
Transform drug development with our tailored services. From predictive modeling to market access strategies, Certara’s integrated services enhance decision-making, streamline processes, and make your drug a safer bet.
Optimize drug development using predictive biosimulation and modeling to inform dosing, safety, and efficacy decisions.
Deliver submission-ready datasets and analyses with advanced programming, validation, and data standardization.
Streamline development with tailored MIDD driven strategies through all phases of development to optimize execution and decision-making.
Ensure global compliance and impactful medical narratives with expert regulatory documentation and strategy.
Leverage real-world data to craft value propositions, engage payers, and secure market access.
Centers of Excellence that address complex therapeutic challenges with specialized expertise in oncology, pediatrics, rare diseases, and more.
Certara tailors solutions for biotech, pharma, and CROs, addressing unique challenges to drive success.
Fuel your breakthrough pipeline. With tailored guidance and integrated services, Certara helps biotech companies transform one success into sustainable growth and attract critical investment.
Open up silos, prioritize effectively. Certara empowers large pharma to optimize decision-making, align priorities, and achieve delivery across global teams and complex pipelines.
Maximize efficiency, align seamlessly. Certara’s cutting-edge solutions ensure CROs stay ahead, improve client alignment, and deliver results with unmatched speed and precision.
Certara collaborates with leading biotech, pharma, and CRO partners to tackle complex challenges, deliver innovation, and shape the future of healthcare.
With over 1,000 articles spanning categories and solutions, Certara’s resources is a geek haven. It’s all here—built for scientists who dare to think different.
Access expert articles, videos, and tools for drug development innovation.
Experience Certara’s Technology in Drug Development.
Upskill your team with immersive, hands-on modules across multiple domains.
Leverage our expert forums and resources to optimize Certara solutions.
Stay updated on industry trends, best practices, and scientific insights.
Join global experts for live and on-demand knowledge-sharing sessions.
Explore real-world examples of success powered by Certara expertise.
In depth coverage of selected biosimulation and data science topics
With over 1,550+ employees in more than 30 countries, over 28% of which have PhDs, our vision is to transform drug development for good.
Meet the visionary team driving Certara’s innovation and growth.
Explore Certara’s global network of offices, serving clients worldwide.
Access financial reports, investor updates, and shareholder resources.
Discover how collaborations amplify our impact across the drug development ecosystem.
Learn about regulatory agencies worldwide leveraging Certara solutions.
See how Certara prioritizes sustainability, diversity, and community impact.
Stay informed with the latest press coverage, press releases, and announcements.
Understand our commitment to data privacy, compliance, and security.
Join a global leader transforming the future of drug development. Explore opportunities to innovate, grow, and make a difference in transforming lives.
Home / Legal Notice / Real‐world study of patients who restarted treatment with cannabidiol (Epidyolex®)
